chr1-179882522-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015602.4(TOR1AIP1):c.20G>A(p.Arg7Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000383 in 1,306,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015602.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOR1AIP1 | NM_015602.4 | c.20G>A | p.Arg7Gln | missense_variant | 1/10 | ENST00000606911.7 | NP_056417.2 | |
TOR1AIP1 | NM_001267578.2 | c.20G>A | p.Arg7Gln | missense_variant | 1/10 | NP_001254507.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOR1AIP1 | ENST00000606911.7 | c.20G>A | p.Arg7Gln | missense_variant | 1/10 | 1 | NM_015602.4 | ENSP00000476687.1 | ||
TOR1AIP1 | ENST00000271583.7 | c.20G>A | p.Arg7Gln | missense_variant | 1/11 | 5 | ENSP00000271583.3 | |||
TOR1AIP1 | ENST00000528443.6 | c.20G>A | p.Arg7Gln | missense_variant | 1/10 | 2 | ENSP00000435365.2 | |||
ENSG00000272906 | ENST00000610272.1 | n.74C>T | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000383 AC: 5AN: 1306498Hom.: 0 Cov.: 29 AF XY: 0.00000787 AC XY: 5AN XY: 634944
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2Y Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 25, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with TOR1AIP1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces arginine with glutamine at codon 7 of the TOR1AIP1 protein (p.Arg7Gln). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and glutamine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at